Last reviewed · How we verify
Spot ALA 2 hour incubation
Spot ALA 2 hour incubation is a Small molecule drug developed by DUSA Pharmaceuticals, Inc.. It is currently in Phase 2 development. Also known as: Levulan.
At a glance
| Generic name | Spot ALA 2 hour incubation |
|---|---|
| Also known as | Levulan |
| Sponsor | DUSA Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spot ALA 2 hour incubation CI brief — competitive landscape report
- Spot ALA 2 hour incubation updates RSS · CI watch RSS
- DUSA Pharmaceuticals, Inc. portfolio CI
Frequently asked questions about Spot ALA 2 hour incubation
What is Spot ALA 2 hour incubation?
Spot ALA 2 hour incubation is a Small molecule drug developed by DUSA Pharmaceuticals, Inc..
Who makes Spot ALA 2 hour incubation?
Spot ALA 2 hour incubation is developed by DUSA Pharmaceuticals, Inc. (see full DUSA Pharmaceuticals, Inc. pipeline at /company/dusa-pharmaceuticals-inc).
Is Spot ALA 2 hour incubation also known as anything else?
Spot ALA 2 hour incubation is also known as Levulan.
What development phase is Spot ALA 2 hour incubation in?
Spot ALA 2 hour incubation is in Phase 2.
Related
- Manufacturer: DUSA Pharmaceuticals, Inc. — full pipeline
- Also known as: Levulan
- Compare: Spot ALA 2 hour incubation vs similar drugs
- Pricing: Spot ALA 2 hour incubation cost, discount & access